- 当前位置:首页 > >Merck Millipore > 生命科学研究
- 生命科学研究
- 产品介绍
重要规格表
品种反应性 主要应用 宿主 格式 抗体类型 H IF M Ascites Monoclonal Antibody 描述 产品目录编号 MAB10215 品牌系列 Chemicon®
商名 - Chemicon
描述 Anti-G1 Protein of La Crosse Virus Antibody, clone 807.33 | MAB10215 背景信息 La Crosse Virus is an arbovirus (a virus transmitted by insects); it is one of the most important mosquito-borne viruses in the United States. La Crosse virus contains two glycoproteins, G1 and G2, the larger of which, G1, is the target of neutralizing antibodies. 产品信息 格式 Ascites 演示 Liquid ascites fluid containing no preservatives. 应用 主要应用 - Immunofluorescence
生物信息 免疫原品种 G1 protein of La Crosse Virus 克隆 807.33 宿主 Mouse 特异性 G1 protein of La Crosse Virus 同种型 IgG2a 品种反应性 Human 抗体类型 Monoclonal Antibody 纯化方法 Ascites 产品使用声明 使用声明 - Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
储存和货运信息 存储条件 1 year at -20°C from date of shipment 包装信息 数量 100 µL
上一件merck millipore产品:merck millipore,默克密理博,AB5848,Anti-GABA B Receptor R2 Antibody, a.a. 42-54 rat
下一件merck millipore产品:merck millipore,默克密理博,AB5580-200UL,Anti-SCN8A Sodium Channel Antibody
merck millipore,默克密理博,444158,MDMX Inhibitor, NSC207895 - Calbiochem
merck millipore,默克密理博,07-224,Anti-phospho-STAT2 (Tyr689) Antibody
merck millipore,默克密理博,EZHFGF21-19K,Human FGF-21 ELISA Kit
merck millipore,默克密理博,MAB2021Z,Anti-Integrin αV Antibody, extracellular, clone AV1, azide free
merck millipore,默克密理博,AB5848,Anti-GABA B Receptor R2 Antibody, a.a. 42-54 rat
merck millipore,默克密理博,AB5580-200UL,Anti-SCN8A Sodium Channel Antibody
merck millipore,默克密理博,07-375,Anti-Ubiquitin Antibody
merck millipore,默克密理博,0110-3500,Guava EasyCyte Mini IQ/OQ Document
merck millipore,默克密理博,MABF712,Anti-CD54 (ICAM-1) Antibody (human), APC, clone 15.2



